Impact of cardiovascular risk factors on vessel wall inflammation and calcified plaque burden differs across vascular beds: a PET-CT study Frederik F. StroblAxel RomingerSarah WolpersCarsten Rist • Fabian BambergKolja M. ThierfelderKonstantin Nikolaou • Christopher UebleisMarcus HackerMaximilian F.
暂无分享,去创建一个
A. Rominger | M. Hacker | C. Rist | T. Saam | K. Nikolaou | F. Strobl | M. Reiser | S. Wolpers | F. Bamberg | K.M. Thierfelder | Christopher Uebleis
[1] J. Alsac,et al. Comparison of 18F-fluoro-deoxy-glucose, 18F-fluoro-methyl-choline, and 18F-DPA714 for positron-emission tomography imaging of leukocyte accumulation in the aortic wall of experimental abdominal aneurysms. , 2012, Journal of vascular surgery.
[2] E. Dolan,et al. Carotid plaque inflammation on 18F‐fluorodeoxyglucose positron emission tomography predicts early stroke recurrence , 2012, Annals of neurology.
[3] Claudia Calcagno,et al. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study. , 2011, JACC. Cardiovascular imaging.
[4] Agnes Pasquet,et al. Imaging the vulnerable plaque. , 2011, Journal of the American College of Cardiology.
[5] Robert J. Hinchliffe,et al. Pathophysiology and epidemiology of abdominal aortic aneurysms , 2011, Nature Reviews Cardiology.
[6] M. Reiser,et al. Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[7] David M. Williams,et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Th , 2010, Anesthesia and analgesia.
[8] M. Reiser,et al. 18F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease , 2009, Journal of Nuclear Medicine.
[9] V. Fuster,et al. Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers: A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study , 2009, Circulation. Cardiovascular imaging.
[10] Michael Motro,et al. Calcification of the Thoracic Aorta as Detected by Spiral Computed Tomography Among Stable Angina Pectoris Patients: Association With Cardiovascular Events and Death , 2008, Circulation.
[11] W. Oyen,et al. In Vivo Imaging of Abdominal Aortic Aneurysms: Increased FDG Uptake Suggests Inflammation in the Aneurysm Wall , 2008, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[12] Sameer Bansilal,et al. Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations , 2008, Journal of Nuclear Medicine.
[13] W S Kerwin,et al. MR imaging of adventitial vasa vasorum in carotid atherosclerosis , 2008, Magnetic resonance in medicine.
[14] V. Fuster,et al. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. , 2007, Journal of the American College of Cardiology.
[15] Daniel S Berman,et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. , 2007, Journal of the American College of Cardiology.
[16] T. Imaizumi,et al. Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. , 2007, Journal of the American College of Cardiology.
[17] Ahmed Tawakol,et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. , 2006, Journal of the American College of Cardiology.
[18] A. Freiman,et al. Association of vascular 18F-FDG uptake with vascular calcification. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] E. Isselbacher. Thoracic and Abdominal Aortic Aneurysms , 2005, Circulation.
[20] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[21] J. Pickard,et al. Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.
[22] N. Kouchoukos,et al. Atherosclerosis of the ascending aorta is an independent predictor of long-term neurologic events and mortality. , 1999, Journal of the American College of Cardiology.
[23] Daniel Levy,et al. Lifetime risk of developing coronary heart disease , 1999, The Lancet.
[24] C. Tzourio,et al. [Evaluation of aortic atherosclerosis by transesophageal echocardiography. Prognostic implications]. , 1997, Archives des maladies du coeur et des vaisseaux.
[25] K. Newman,et al. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. , 1994, Circulation.
[26] I. Kronzon,et al. High Risk for Vascular Events in Patients with Protruding Aortic Atheromas: A Prospective Study , 1994, Journal of the American College of Cardiology.
[27] W. Pearce,et al. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. , 1990, The American journal of pathology.
[28] L. Melton,et al. Thoracic aortic aneurysms: a population-based study. , 1982, Surgery.
[29] L. Norgren,et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, Journal of vascular surgery.
[30] C. Doherty,et al. Vascular events during follow-up in patients with aortic arch atherosclerosis. , 1997, Stroke.
[31] D. Clement. A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .